Troponins in prediction of cardiotoxic effects [14]

Lancet

Volumn 357, Issue 9258, 2001, Pages 808-

  Auner, Holger W ^a   Tinchon, Christoph ^a   Quehenberger, Franz ^a   Linkesch, Werner ^a   Sill, Heinz ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; TROPONIN;

CANCER CHEMOTHERAPY; CARCINOMA; CARDIOTOXICITY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE PREDISPOSITION; HEART FUNCTION; HEART MUSCLE; HUMAN; LETTER; MUSCLE FIBRIL; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0035836006     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71241-1     Document Type: Letter

References (5)

1. Troponins for predicting cardiotoxicity from cancer therapy
2. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity
3. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury
4. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis
5. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy